| Code | CSB-MP819484HU |
| Abbreviation | Recombinant Human LRRC15 protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
LRRC15 is upregulated in cancer-associated fibroblasts and correlates with tumor progression in multiple solid malignancies, making it a target of interest for stromal biology and immunotherapy research. This mammalian-expressed construct spanning residues 22–538 captures the complete leucine-rich repeat ectodomain, and functional ELISA demonstrates specific antibody binding with an EC50 of 12.18–15.75 ng/mL, confirming native epitope presentation suitable for antibody development and validation workflows. The quantified binding activity supports use in cell adhesion and spreading assays where LRRC15-mediated interactions govern fibroblast behavior, as well as in tumor metastasis models examining stromal-tumor crosstalk. Purity exceeding 90% by SDS-PAGE and endotoxin below 1.0 EU/μg align with standards expected in cell-based migration and invasion assays, where low endotoxin is critical to avoid confounding inflammatory responses.
There are currently no reviews for this product.